Lymphoma, Non-Hodgkin: all 2,043 studies

Page 20 of 21. Open to participants first (309), then studies with results posted, then the rest; newest registration first within each.

• Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory LymphomaTerminatedNCT00036855Phase 1
• Idiotype Vaccine for Low-Grade Non-Hodgkin's LymphomaStatus unknownNCT00036426Phase 2
• Radiolabeled Monoclonal Antibody in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaTerminatedNCT00033423Phase 1
• CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's LymphomaCompletedNCT00033267Phase 2
• Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00032019Phase 2
• Rituximab Plus Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's LymphomaStatus unknownNCT00031902Phase 1
• Radiation Therapy in Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell TransplantationCompletedNCT00031668Not applicable
• Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's LymphomaStatus unknownNCT00028717Phase 3
• Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's LymphomaCompletedNCT00028665Phase 2
• Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or LymphomaCompletedNCT00027937Phase 2
• Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerCompletedNCT00027820Phase 1/2
• Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's LymphomaCompletedNCT00026910
• Denileukin Diftitox in Treating Patients With Non-Hodgkin's LymphomaStatus unknownNCT00026429Phase 2
• Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00026351Phase 2
• Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's LymphomaCompletedNCT00026182Phase 2
• Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver DysfunctionCompletedNCT00025415Phase 1
• BL22 Immunotoxin in Treating Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaWithdrawnNCT00024115Phase 1
• Expanded Access Study of Iodine-131 Anti-B1 AntibodyStatus unknownNCT00022958Not applicable
• Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade Non-Hodgkin's Lymphoma Following First Line CHOPStatus unknownNCT00022932Phase 2
• Safety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow InvolvementStatus unknownNCT00022906Phase 1
• Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for the Retreatment of Patients With Non-Hodgkin's LymphomaStatus unknownNCT00022893Not applicable
• Epratuzumab in Treating Patients With Non-Hodgkin's LymphomaStatus unknownNCT00022685Phase 3
• Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00022581Phase 2
• Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related LymphomaCompletedNCT00022555Phase 1
• Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00021372Phase 2
• Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaTerminatedNCT00019708Phase 1
• Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's LymphomaCompletedNCT00018954Phase 2
• Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00017381Early Phase 1
• Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's LymphomaStatus unknownNCT00017290Phase 3
• S0108 Bevacizumab in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00016094Phase 2
• Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaStatus unknownNCT00014664Phase 2
• Involved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's LymphomaTerminatedNCT00014326Phase 3
• Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic MalignanciesCompletedNCT00014235Not applicable
• Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous TreatmentCompletedNCT00014209Phase 2
• Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic MalignanciesCompletedNCT00013533Early Phase 1
• Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or LymphomasCompletedNCT00012181Phase 1
• Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00012051Phase 3
• Rituximab Plus Interleukin-2 in Treating Patients With Hematologic CancerCompletedNCT00010192Phase 1
• Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's LymphomaStatus unknownNCT00009776Phase 1
• Monoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's LymphomaStatus unknownNCT00008021Phase 1
• S0019 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaTerminatedNCT00006708Phase 3
• Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplant in Non-Hodgkin's LymphomaCompletedNCT00006695Phase 2
• Rituximab Followed by Combination Chemotherapy in Treating Patients With Refractory or Recurrent Non-Hodgkin's LymphomaWithdrawnNCT00006669Phase 2
• Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00006473Phase 2
• Tumor Lysate Pulsed-Dendritic Cell Vaccines After High-Dose Chemotherapy for Non-Hodgkin's LymphomaCompletedNCT00006434Phase 3
• Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's LymphomaCompletedNCT00006383Phase 2
• Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic CancerCompletedNCT00006251Phase 1/2
• Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Low- or Intermediate-Grade Non-Hodgkin's LymphomaCompletedNCT00006241Phase 2
• Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's LymphomaCompletedNCT00006125Phase 2
• PS-341 in Treating Patients With Hematologic CancerCompletedNCT00006098Phase 1
• Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's LymphomaCompletedNCT00006039Phase 2
• Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's DiseaseWithdrawnNCT00005998Phase 2
• Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic LeukemiaCompletedNCT00005977Phase 3
• Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's LymphomaCompletedNCT00005964Phase 2
• Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's LymphomaStatus unknownNCT00005959Phase 2
• Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's LymphomaCompletedNCT00005867Phase 3
• Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous TreatmentCompletedNCT00005811Phase 2
• Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerCompletedNCT00005799Not applicable
• Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or LeukemiaTerminatedNCT00005786Not applicable
• Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's LymphomaCompletedNCT00005601Phase 2
• Radioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00005592Phase 2
• Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's LymphomaCompletedNCT00005580Phase 1
• S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's LymphomaCompletedNCT00005089Phase 2
• 506U78 in Treating Patients With LymphomaCompletedNCT00005080Phase 2
• Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's LymphomaCompletedNCT00005040Phase 2
• Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's LymphomaCompletedNCT00004908Phase 2
• Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic LeukemiaCompletedNCT00004898Phase 1/2
• Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's LymphomaTerminatedNCT00004874Phase 3
• Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkin's LymphomaStatus unknownNCT00004858Phase 1
• Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00004260Phase 1
• 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or SarcomaCompletedNCT00004241Phase 1
• Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's LymphomaCompletedNCT00004192Phase 2
• Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's LymphomaCompletedNCT00004179Phase 3
• Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's LymphomaCompletedNCT00004171Phase 2
• Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's LymphomaCompletedNCT00004162Phase 1
• Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's LymphomaCompletedNCT00004112Phase 3
• Monoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's LymphomaCompletedNCT00004101Phase 1
• Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or LymphomaCompletedNCT00003970Phase 1
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's LymphomaCompletedNCT00003957Phase 2
• Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's LymphomaStatus unknownNCT00003942Phase 1/2
• Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's LymphomaStatus unknownNCT00003924Phase 3
• Diagnostic Study of Patients With Aggressive Non-Hodgkin's LymphomaCompletedNCT00003863
• Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's DiseaseCompletedNCT00003849Phase 2
• Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's LymphomaStatus unknownNCT00003815Phase 3
• S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00003784Phase 2
• Combination Chemotherapy in Treating Children With Non-Hodgkin's LymphomaCompletedNCT00003650Phase 3
• Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's LymphomaStatus unknownNCT00003639Phase 3
• Denileukin Diftitox in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00003615Phase 2
• O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell LymphomaTerminatedNCT00003613Phase 1
• Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's LymphomaCompletedNCT00003595Phase 3
• Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's LymphomaCompletedNCT00003575Phase 2
• Antineoplaston Therapy in Treating Patients With High-Grade Stage II - Stage IV Non-Hodgkin's LymphomaTerminatedNCT00003501Phase 2
• Antineoplaston Therapy in Treating Patients With Intermediate-Grade Stage II - IV Non-Hodgkin's LymphomaTerminatedNCT00003500Phase 2
• Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced CancerCompletedNCT00003451Phase 1
• Combination Chemotherapy in Treating Children With Non-Hodgkin's LymphomaStatus unknownNCT00003423Phase 3
• Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00003402Phase 2
• Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's LymphomaStatus unknownNCT00003338Phase 2/3
• Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's LymphomaStatus unknownNCT00003337Phase 3
• Radiation Therapy and High-Dose Corticosteroids in Treating Older Patients With Primary CNS Non-Hodgkin's LymphomaCompletedNCT00003278Phase 2
• Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's LymphomaCompletedNCT00003245Phase 2

← Lymphoma, Non-Hodgkin overview